Scientific Letter
Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
1Department of Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
2Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
2Department of General Internal Medicine, Faculty of Medicine, Hacettepe University; Ankara-Turkey
Keywords: COVID-19, Angiotensin receptor blockers, Angiotensin Enzyme Inhibitors, Statins, Heparin